The goal of the study is to evaluate the effectiveness of an investigational eye drop medication compared to a *placebo in volunteers with allergic conjunctivitis, or eye allergies. (*A placebo is a substance or treatment without real medical effects and is often used in studies to compare against the real treatment.)
The study will last about 5-6 weeks and includes up to six (6) in-clinic visits. Eligible participants may receive up to $1700 in compensation for completing all required study visits.
To determine if you are eligible to participate, please complete the form below. Our patient experience team will contact you to ask more questions and provide more information about the study.
You may qualify to participate if you:
Are 18 years or older
Have a history of ocular allergies (grass, ragweed, tree pollen, cat/dog dander, dust mites, cockroach)
Are willing to discontinue use of contact lenses 24 hours prior to every study visit
Have NOT undergone ocular surgery in the last 3 months and no planned surgeries of any kind during study participation
If you qualify for this study, here is what you can expect:
· Study Visits: You will be asked to attend six (6) in-clinic visits over approximately 5-6 weeks.
· Compensation: For your time and participation and for completing all required study visits, you may be compensated up to $1,700.
During these visits, you will go through a series of assessments, including:
· Skin Test: If an allergy skin test is not on file in the last 5 years a new test will be done to confirm your reaction to seasonal and perennial allergens.
· Eye Exam: You will receive a comprehensive eye examination to assess your eye health.
· Eye Imaging: You will undergo an eye scan using the investigational device.
· Medical History: We will ask for your medical history and current medications, vitamins, and other supplements that you take. You will also be asked questions about your overall health, past diseases, and surgeries.
· Questionnaires: You will be asked to complete various study questionnaires to provide valuable information.
In addition, there are other assessments that the study team will discuss with you in detail during your visits.
We are currently conducting this study nationwide, with new locations coming soon. Take a look at our current locations below to find out if we have a study location near you.
The study will last approximately 5-6 weeks and involves up to 6 in–person visits.
Taking part in any clinical study is entirely voluntary. Your decision whether or not to participate will not affect the medical care you currently receive or may receive in the future. If you qualify and opt to join the study, you have the freedom to withdraw at any time and for any reason.
Your personal and medical information is completely protected before, during and after the clinical trial process through the HIPAA (Health Insurance Portability and Accountability Act) Privacy Rule. You will also be informed of who has access to your personal information.
Telios Pharma, Inc. is responsible for conducting this clinical study.
Key Inclusion Criteria
Key Exclusion Criteria
Sign up for email alerts when new trials and locations are added for a medical condition.
